Serina Therapeutics
25 hedge funds and large institutions have $1.9M invested in Serina Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
19% more capital invested
Capital invested by funds: $1.6M → $1.9M (+$305K)
0% more funds holding
Funds holding: 25 → 25 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.21% less ownership
Funds ownership: 3.59% → 3.38% (-0.21%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$62.4K |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$16.8K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$18.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$4.73K |
| 4 |
BlackRock
New York
|
-$2.39K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$501 |
SER Hedge Fund Activity: Q1 2025 in Review
25 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2025, worth a combined $1.9M — up 19% from $1.6M a quarter earlier.
Fund positioning in SER was balanced in Q1 2025: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $62.4K. The largest seller was Millennium Management, cutting an estimated $18.1K.
- 25 institutional investors held Serina Therapeutics (SER) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $1.9M of Serina Therapeutics stock for Q1 2025, up 19% quarter-over-quarter.
- 3 funds opened new Serina Therapeutics positions in Q1 2025 and 3 closed out, a net change of 0 holders.
- The largest Serina Therapeutics buyer in Q1 2025 was Citadel Advisors, an estimated $62.4K added.
- The largest Serina Therapeutics seller in Q1 2025 was Millennium Management, an estimated $18.1K sold.
Based on aggregated 13F filings for Q1 2025.